53581-06-9 Usage
Molecular structure
A complex chemical compound with a benzyl group, an amino and methoxy substitution, a propyl group, and a tetrahydroisoquinoline ring.
Pharmacological properties
Potential applications in medicinal chemistry for the development of novel drugs targeting specific receptors or pathways in the body.
Structural features
The presence of an amino group and a methoxy group on the benzyl ring, as well as the propyl group attached to the tetrahydroisoquinoline ring, may contribute to its pharmacological properties.
Neuroactive properties
The compound's structure suggests that it may have neuroactive properties, which could be relevant for its potential applications in neuroscience and drug discovery.
Further research
Additional studies are needed to explore the compound's potential applications in neuroscience and drug discovery, as well as to better understand its pharmacological properties and mechanisms of action.
Potential drug development
Due to its complex structure and potential pharmacological properties, 1-(2-amino-3-methoxybenzyl)-2-propyl-1,2,3,4-tetrahydroisoquinoline may be a promising candidate for the development of new drugs targeting specific receptors or pathways in the body.
Chemical classification
As a tetrahydroisoquinoline derivative, 1-(2-amino-3-methoxybenzyl)-2-propyl-1,2,3,4-tetrahydroisoquinoline belongs to a class of alkaloids that are known for their diverse range of biological activities and potential applications in medicine.
Synthesis
The synthesis of 1-(2-amino-3-methoxybenzyl)-2-propyl-1,2,3,4-tetrahydroisoquinoline may involve multiple steps, including the formation of the benzyl and propyl groups, as well as the tetrahydroisoquinoline ring.
Stability
The stability of 1-(2-amino-3-methoxybenzyl)-2-propyl-1,2,3,4-tetrahydroisoquinoline under various conditions (e.g., temperature, pH, etc.) would need to be assessed to determine its suitability for pharmaceutical applications.
Safety and toxicity
As with any potential drug candidate, the safety and toxicity profiles of 1-(2-amino-3-methoxybenzyl)-2-propyl-1,2,3,4-tetrahydroisoquinoline would need to be thoroughly evaluated before it could be considered for clinical use.
Check Digit Verification of cas no
The CAS Registry Mumber 53581-06-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,5,8 and 1 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 53581-06:
(7*5)+(6*3)+(5*5)+(4*8)+(3*1)+(2*0)+(1*6)=119
119 % 10 = 9
So 53581-06-9 is a valid CAS Registry Number.
53581-06-9Relevant academic research and scientific papers
Synthesis and dopamine agonist and antagonist effects of (R)-(-)- and (S)-(+)-11-hydroxy-N-n-propylnoraporphine
Gao,Zong,Campbell,Kula,Baldessarini,Neumeyer
, p. 1392 - 1396 (2007/10/02)
The R-(-) and S-(+) enantiomers of 11-hydroxy-N-n-propylnoraporphine, (R)-3 and (S)-3, were synthesized in six steps from 1-(3-methoxy-2-nitrobenzyl)isoquinoline. Neuropharmacological evaluation of the R and S isomers (by affinity to dopamine receptor sit
